Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

Recursion announced that its Board of Directors has unanimously approved a leadership transition plan to become effective January 1, 2026: Najat ...

Abstract: In adversarial environments, unmanned aerial vehicle (UAV) swarms often face challenges such as node failures, battle damage, and strong electromagnetic interference, which may result in ...

Abstract: Aiming at the shortcomings of traditional convolutional neural network methods in capturing long-range spatial dependencies in fine-grained image recognition due to the restricted sensory ...

Gödel's Poetry is an advanced automated theorem proving system that combines Large Language Models (LLMs) with formal verification in Lean 4. The system takes mathematical theorems—either in informal ...